NCT01378143 - Using OCZ103-OS in Patients With Unresectable and Locally Recurrent or Metastatic Colorectal Cancer Undergoing Standard Chemotherapy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

March 31, 2014

Study Completion Date

July 31, 2014

Conditions

Colorectal Cancer

Interventions

DRUG

OCZ103-OS [pentamidine bis(2-hydroxyethanesulfonate)], mFOLFOX6 or FOLFIRI

OCZ103-OS is given in combination with Chemotherapy each cycle

Trial Locations (7)

CSSS Champlain - Charles-Lemoyne Hospital, Greenfield Park

CSSS Alphonse-Desjardins (CHAU Hotel-Dieu de Levis), Lévis

CSSS St-Jérome, St-Jérome

CHUM-St. Luc Hospital, Montreal

Jewish General Hospital, Montreal

Hotel-Dieu de Quebec, Québec

CHUS-Centre de recherche Etienne-Le Bel, Sherbrooke